What's new in DyslipidemiaLast update of the site: Tuesday, 19 September 2023
Wijemunige Nilmini et al. | BMC Public Health 2023; 23(1): 1792
Identification of people at high risk for cardiovascular disease (CVD) and managing them with a combination...
Yin Dongpei et al. | Journal of Neuroinflammation 2023; 20(1):...
Despite considerable progress in acute recanalization therapies (i.e., intravenous thrombolysis and/or...
Garcia Agustin R. et al. | Respiratory Research 2023; 24(1): 223...
Pulmonary arterial hypertension (PAH) is a progressive disease leading to increased pulmonary vascular...
Garcia, Rosana Lima et al. | Blood Pressure Monitoring 2023; 28(5):...
Arterial hypertension (AH) is the main modifiable risk factor for cardiovascular disease and all-cause...
Rios Santiago et al. | Cardiovascular Diabetology 2023; 22(1):...
The role of lifestyle factors in health has been the object of numerous studies in recent decades. Most...
Huanxian
Liu
MD
et al. | Headache 2023; 63(8): 1109-18
Migraine is a highly prevalent neurovascular disorder affecting more than 1 billion people worldwide....
Morace Carmela et al. | Italian Journal of Pediatrics 2023;...
Endocan, formerly called endothelial cell-specific molecule-1 (ESM-1), is a soluble dermatan sulfate...
Vistisen Dorte et al. | Cardiovascular Diabetology 2023; 22(1):...
Individuals with type 2 diabetes (T2D) are at increased risk for cardiovascular disease (CVD), including...
Shao Yubo et al. | Arthritis Research & Therapy 2023; 25(1):...
Rheumatoid arthritis (RA) is a chronic, systemic, autoimmune disease of unknown etiology with erosive,...
Yi Jiayi et al. | Journal of Translational Medicine 2023;...
Despite decades of declining incidence rates and significant improvements in management and outcomes,...